文献速递急性肾损伤

心脏手术后急性肾损伤的肾小管损伤与功能生物标志物

Kidney Tubular Damage and Functional Biomarkers in Acute Kidney Injury Following Cardiac Surgery.
PubMed 文献 · Kidney Int Rep · 2019-05-18

这项单中心前瞻性队列研究纳入106例接受冠状动脉旁路移植术和/或瓣膜手术并体外循环的成人,评估联合肾功能丧失标志物(血清胱抑素C)和肾小管损伤标志物(尿NGAL和KIM-1)预测术后急性肾损伤(AKI)的价值。主要结局为术后院内AKI(按SCr-KDIGO标准)。结果显示,联合峰值血清胱抑素C与峰值尿KIM-1/肌酐(术后6小时至POD1)高于最佳截断值,与术后AKI显著相关(OR 5.32;95%CI 1.31-21.67;P=0.020),并显著改善临床模型的预测性能(AUC从0.77升至0.83,P=0.049)。

要点

  • 联合肾功能丧失和肾小管损伤标志物可提高心脏手术后AKI预测。
  • 峰值胱抑素C联合尿KIM-1/肌酐与术后AKI独立相关。
  • 该联合标志物显著改善临床模型的预测性能。

核心结论

  • 联合术后肾功能丧失和肾小管损伤生物标志物可显著改善心脏手术后院内AKI的预测。

研究设计与样本

  • 单中心前瞻性队列研究,纳入106例接受冠状动脉旁路移植术和/或瓣膜手术并体外循环的成人。

主要发现

  • 23例(21.7%)发生AKI。
  • 校正术前左心室射血分数、BMI>30 kg/m2和eGFR<60 ml/min per 1.73 m2后,峰值血清胱抑素C与峰值尿KIM-1/肌酐(术后6小时至POD1)高于最佳截断值的组合与术后AKI显著相关(OR 5.32;95%CI 1.31-21.67;P=0.020)。
  • 该生物标志物组合显著改善临床模型预测术后AKI的性能(临床模型单独AUC 0.77,95%CI 0.65-0.90;加入生物标志物后AUC 0.83,95%CI 0.73-0.93;P=0.049)。

关键数值与推荐

  • AKI定义采用血清肌酐-KDIGO标准。
  • 生物标志物在术前、体外循环后6小时及术后第1至4天测量。

临床怎么用

  • 对于心脏手术患者,可考虑联合血清胱抑素C和尿KIM-1/肌酐监测以早期识别AKI高风险者。

局限性

  • 单中心研究,样本量有限,需未来大型多中心研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiac surgery-associated acute kidney injury (AKI) is associated with increased morbidity and mortality. We examined the utility of combining biomarkers of kidney function loss (serum cystatin C) and kidney tubular damage (urine neutrophil gelatinase-associated lipocalin [NGAL] and Kidney Injury Molecule-1 [KIM-1]) for the prediction of post-cardiac surgery AKI. METHODS: Single-center prospective cohort study of 106 adults undergoing coronary artery bypass grafting and/or valve surgery with cardiopulmonary bypass (CPB). Primary outcome was postoperative in-hospital AKI defined by serum creatinine (SCr)-Kidney Disease: Improving Global Outcomes criteria. Biomarkers were measured preoperatively, 6 hours after CPB and on postoperative days (PODs) 1 to 4. RESULTS: A total of 23 subjects (21.7%) developed AKI. After adjusting for preoperative left ventricular ejection fraction, body mass index >30 kg/m2, and estimated glomerular filtration rate (eGFR) <60 ml/min per 1.73 m2, the combination of peak serum cystatin C and peak urine KIM-1/creatinine (Cr) (6 hours post-CPB to POD 1) above optimal cutoff significantly associated with postoperative AKI (odds ratio [OR]: 5.32; 95% confidence interval [CI]: 1.31-21.67; P = 0.020). This biomarker combination significantly improved the performance of the clinical model for the prediction of postoperative AKI (area under the curve [AUC]: 0.77, 95% CI: 0.65-0.90 for the clinical model alone versus 0.83, 95% CI: 0.73-0.93 for the clinical model with the addition of biomarker data, P = 0.049). CONCLUSIONS: Combining biomarkers of postoperative kidney function loss and postoperative kidney tubular damage significantly improved prediction of in-hospital AKI following cardiac surgery. Future large, multicenter studies are warranted to assess whether panels of biomarkers reflecting distinct pathobiology can be used to guide interventions and improve short- and long-term outcomes in patients undergoing cardiac surgery.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Neyra JA, Hu MC, Minhajuddin A, et al. Kidney Tubular Damage and Functional Biomarkers in Acute Kidney Injury Following Cardiac Surgery. Kidney Int Rep. 2019. PMID: 31440703. doi:10.1016/j.ekir.2019.05.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。